Multifunctional theranostic nanocarrier platform for microglia-selective cytochalasin D delivery to modulate neuroinflammation after acute brain injuries
Biomaterials, vol. 337, pp. 124495
Abstract
Targeting microglia to modulate neuroinflammation after acute brain injuries (ABIs) is promising but limited by poor blood-brain barrier (BBB) penetration and systemic toxicity of candidate agents. In addition, multifunctional platforms combining targeted therapy with real-time traceability remain limited. We developed and characterized a multifunctional theranostic, folate-functionalized, polydopamine (PDA)-coated mesoporous silica nanoparticle (FA-NP) system for microglia-selective delivery and intracellular release of cytoskeleton inhibitor Cytochalasin D (CytoD). FA-NPs exhibited ideal physicochemical properties for parenchymal brain accumulation and pH-sensitive PDA shells enabled intracellular retention and gradual degradation. Using radiolabeled and fluorescein-isothiocyanate-functionalized FA-NPs, SPECT/CT imaging, γ-counting, autoradiography, and immunohistochemistry confirmed parenchymal brain accumulation with cellular uptake following systemic administration. Activated microglia upregulated folate receptors (FOLR1/2) and internalized FA-NPs via FOLR-mediated, dynamin-dependent endocytosis. CytoD-loaded FA-NPs (FA-NP[CytoD]) significantly reduced microglial migration, phagocytosis, ROS production, and proinflammatory cytokines, outperforming molecular CytoD while exhibiting notably lower toxicity compared to both CytoD and unfunctionalized particles. In organotypic brain slice models of hypoxia-reoxygenation and traumatic injury, FA-NP[CytoD] reduced inflammation at 24 and 96 h. Systemic administration enabled brain accumulation with clearance over time. Together, this multifunctional theranostic platform integrates selective microglial targeting, controlled drug release, and multimodal imaging, offering translational potential for ABIs.
Authors 15
-
University of Oxford · Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom
-
Stanford Medicine · Stanford University
Affiliation as printed
Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA, 94305, USA
-
Brigham and Women's Hospital · Harvard University · University of Oxford
Affiliation as printed
Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02120, USA
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Neurology, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Neurology, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany
-
Affiliation as printed
Institute of Inorganic and Materials Chemistry, University of Cologne, Cologne, 50939, Germany
-
Affiliation as printed
Institute of Inorganic and Materials Chemistry, University of Cologne, Cologne, 50939, Germany
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Neurology, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany
-
Maastricht University Medical Centre · Maastricht University · Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, 6202, The Netherlands
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Electron Microscopy Facility, Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany
-
Forschungszentrum Jülich · University of Cologne · University Hospital Cologne
Affiliation as printed
Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, University of Cologne, Cologne, 50937, Germany; Institute of Neuroscience and Medicine, Forschungszentrum Jülich GmbH, Jülich, 52425, Germany
-
Affiliation as printed
Institute of Inorganic and Materials Chemistry, University of Cologne, Cologne, 50939, Germany
-
Jörg B. Schulz Aachen Department of Neurology JARA-BRAIN Institute of Molecular Neuroscience and Neuroimaging
Forschungszentrum Jülich · Universitätsklinikum Aachen · Jülich Aachen Research Alliance · RWTH Aachen University
Affiliation as printed
Department of Neurology, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany; JARA-BRAIN Institute of Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, 52074, Germany
-
Maastricht University Medical Centre · Maastricht University · Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, 6202, The Netherlands
-
Universitätsklinikum Aachen · Stanford Medicine · RWTH Aachen University · Stanford University
Affiliation as printed
Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA, 94305, USA; Department of Neurology, University Hospital Aachen, RWTH Aachen University, Aachen, 52074, Germany. Electronic address: phabib@stanford.edu
Cited by 1 stored of 1
1 result
No patents citing this paper on Lens.org (checked 2026-10-06).